Similarly, multiple in vitro studies demonstrated that GRP94 knockdown facilitated growth inhibition in various cancer cell lines, such as gastric cancer, breast cancer, and colorectal cancer cells [99,109,110]. This evidence concerns the gene HSP90B1 and breast carcinoma.